These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33140857)

  • 1. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
    Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
    BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
    Cusan M; Mungo G; De Marco Zompit M; Segatto I; Belletti B; Baldassarre G
    Front Endocrinol (Lausanne); 2018; 9():393. PubMed ID: 30065701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p27
    Berton S; Cusan M; Segatto I; Citron F; D'Andrea S; Benevol S; Avanzo M; Dall'Acqua A; Schiappacassi M; Bristow RG; Belletti B; Baldassarre G
    Sci Rep; 2017 Apr; 7(1):595. PubMed ID: 28377607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27
    Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
    Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
    Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
    PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function.
    Bencivenga D; Stampone E; Aulitto A; Tramontano A; Barone C; Negri A; Roberti D; Perrotta S; Della Ragione F; Borriello A
    Mol Oncol; 2021 Apr; 15(4):915-941. PubMed ID: 33316141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEN4 and
    Alrezk R; Hannah-Shmouni F; Stratakis CA
    Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
    Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.
    Occhi G; Regazzo D; Trivellin G; Boaretto F; Ciato D; Bobisse S; Ferasin S; Cetani F; Pardi E; Korbonits M; Pellegata NS; Sidarovich V; Quattrone A; Opocher G; Mantero F; Scaroni C
    PLoS Genet; 2013 Mar; 9(3):e1003350. PubMed ID: 23555276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women.
    Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H
    Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
    Jiang D; Wang X; Liu X; Li F
    Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.